Testicular carcinoma. A curable malignancy.
The progress in the management of testicular germ cell tumours is reviewed. A marked improvement of the treatment results has been obtained in non-seminomas, especially by the use of cis-platinum based chemotherapy. At present long term survival can be expected in 85 per cent of all non-seminomas and in 95 per cent of all seminomas after adequate treatment. The natural history of the disease, symptomatology, diagnostic procedures, staging and different treatment modalities, as surgery, radiation therapy, chemotherapy and their combination, are discussed.
Dahl
O
O
D003131:Combined Modality Therapy; D004407:Dysgerminoma / Q000628:therapy; D006801:Humans; D008297:Male; D008649:Mesonephroma / Q000628:therapy; D009367:Neoplasm Staging; D009373:Neoplasms, Germ Cell and Embryonal / Q000175:diagnosis / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D011379:Prognosis; D012537:Scandinavian and Nordic Countries; D013724:Teratoma / Q000628:therapy; D013736:Testicular Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*